Share this post on:

Product Name :
STM-2457

Search keywords :
STM2457

drugId :
null

Target Vo:
N6-adenosine-methyltransferase catalytic subunit

Target Vo Short Name :
METTL3

Moa_Name:
N6-adenosine-methyltransferase catalytic subunit modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Cambridge

Active Company_Name :
Storm Therapeutics Ltd

Active Indication_Name:
Leukemia, Myeloid

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Tisotumab MedChemExpress
EGFR Rabbit mAb Autophagy
SOX11 Antibody: SOX11 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 47 kDa, targeting to SOX11. It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Share this post on:

Author: Interleukin Related